Farmakopea Sodium Phosphate

Rectal Solution

Sodium Phosphate Rectal Solution Farmakopea sodium acid phosphate enema 120 ml

WHAT IT'S FOR

Sodium Phosphate Rectal Solution Farmakopea is a drug based on the active ingredient Monobasic Sodium Phosphate Dihydrate + Dibasic Disodium Phosphate Dodecahydrate, belonging to the category of Laxatives and specifically Enemas. It is marketed in Italy by FederFARMA.CO SpA.

Sodium Phosphate Rectal Solution Farmakopea can be prescribed with SOP Recipe - non-prescription but not over-the-counter medicines.

Sodium Phosphate Rectal Solution Farmakopea is used for the therapy and treatment of various diseases and pathologies such as Constipation.

 

COMMERCIAL INFORMATION REGARDING THE PRESCRIPTION

Owner: Farmakopea SpA
Dealer: FederFARMA.CO SpA
Recipe: SOP - non-prescription but non-over-the-counter medicines
Class: C
Active ingredient: Monobasic Sodium Phosphate Dihydrate + Dibasic Disodium Phosphate Dodecahydrate
Therapeutic group: Laxatives
Pharmaceutical form: enema

INDICATIONS

Treatment of constipation.
Clinical conditions that require pre and post-operative intestinal emptying, in preparation for radiological examinations and endoscopic investigations of the last intestinal tract.

DOSAGE

Adults and adolescents (12 - 18 years): 1 bottle of 120 ml.
Do not use more than one bottle per day.
Each bottle is to be used for one administration only; any remaining medicine must be discarded.
Administration can be practiced at room temperature. If you prefer lukewarm, just put the bottle in contact with hot water (by immersion or under the tap). For a better effect it is advisable to practice the administration in a lying position on the left side. For a greater cleaning action, assume the genupectoral position for a few minutes, immediately after administration.
Instructions for Use

Screw the cannula onto the bottle.
Grasp the bottle and gently introduce the cannula into the rectum, then squeeze the bottle thoroughly. A residue of solution is expected to remain in the bottle.
At the end of the administration, remove the cannula and discard the empty bottle in its own box according to the rules for disposal of medicines.
Remain lying down until an urgent need to evacuate, which usually occurs within 5 minutes.

In any case, it is not necessary to hold the enema for more than 10-15 minutes.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients.
acute abdominal pain or of unknown origin,
nausea or vomiting,
intestinal obstruction or stricture or anorectal stricture,
intestinal subocclusion,
ileus ...

SPECIAL WARNINGS AND USAGE PRECAUTIONS

The 120 ml bottle is not for use in children under 12 years of age.
The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause ...

INTERACTIONS WITH OTHER MEDICINES AND OTHER FORMS OF INTERACTION

Systemic absorption of sodium phosphate rectal solution is limited; however in some conditions it may be increased and predispose to possible interactions with other drugs.
The simultaneous intake of drugs that can ...

Before taking "Sodium Phosphate Rectal Solution Farmakopea" together with other drugs such as, etc .., ask your doctor or pharmacist to verify that it is safe and not harmful to your health ...

TAKE SODIUM PHOSPHATE RECTAL SOLUTION FARMAKOPEA DURING PREGNANCY AND BREASTFEEDING

Can I take Farmakopea Sodium Phosphate Rectal Solution while pregnant and breastfeeding?
There have been no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding.
Although there are no obvious contraindications to the use of the medicine in pregnancy and during ...

EFFECTS ON THE ABILITY TO DRIVE VEHICLES AND ON THE USE OF MACHINERY

The medicine does not affect the ability to drive or use machines. However, it is possible that side effects may occur during treatment, so it is good to know the ...

SIDE EFFECTS

The following are sodium phosphate side effects organized according to the MedDRA system organ class. Insufficient data are available to establish the frequency of the individual effects listed.
...

OVERDOSE

The most frequently observed effect following ingestion or rectal administration is gastrointestinal irritation (abdominal pain, nausea, vomiting, diarrhea). Persistent diarrhea results in loss of water, mineral salts (especially ...

PHARMACODYNAMIC PROPERTIES

Pharmacotherapeutic group: laxatives, ATC code: A06AG01
The laxative effect of sodium phosphate administered rectally is due to an osmotic action. The saline solution is able to recall ...

PHARMACOKINETIC PROPERTIES

When administered rectally it is not absorbed, except in cases where there is damage to the rectal mucosa or other pathological intestinal changes.
...

PRECLINICAL SAFETY DATA

Preclinical data have little clinical relevance in light of the extensive experience acquired with the use of the drug in humans.
Reproductive risk studies of sodium phosphate in animals have not been conducted.
...

LIST OF EXCIPIENTS

100 ml of solution contain:
methyl p-hydroxybenzoate (E218), propyl p-hydroxybenzoate (E216), purified water.
...

EQUIVALENT DRUGS

The equivalent drugs of Sodium Phosphate Rectal Solution Farmakopea based on Monobasic Sodium Phosphate Dihydrate + Disodium Phosphate Dibasic Dodecahydrate are: ...

FOREIGN DRUGS

To know the foreign drugs that correspond to Sodium Phosphate Farmakopea Rectal Solution based on Monobasic Sodium Phosphate Dihydrate + Disodium Phosphate Dibasic Dodecahydrate